Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan

NCT06108063 is registered in ClinicalTrials.gov with Steadman Philippon Research Institute as lead sponsor.

NCT NCT06108063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06108063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan
Lead sponsor
Steadman Philippon Research Institute
Phase
Phase 1/2
Overall status
Recruiting
Start date
March 6, 2024
Completion date
June 30, 2027
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

knee arthroplasty, total